Ailsa Langford
Impact in
-
- Occupational and environmental lung diseases
- Pleural and Pulmonary Diseases
- Prostate Cancer Treatment and Research
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
-
- Cancer Immunotherapy and Biomarkers
- Peptidase Inhibition and Analysis
Papers in
-
- Prostate Cancer Treatment and Research 3
- Occupational and environmental lung diseases 2
-
- Radiopharmaceutical Chemistry and Applications 2
- Co-authors
- Martin R. Stockler (5 shared papers)Sonia Yip (5 shared papers)Nick Pavlakis (2 shared papers)Chris Brown (2 shared papers)Wei‐Sen Lam (2 shared papers)Brett Hughes (2 shared papers)Anna K. Nowak (2 shared papers)Peey‐Sei Kok (2 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Quality of Life Research (1 paper)The Lancet Oncology (1 paper)British Journal of Urology (1 paper)The Sydney eScholarship Repository (The University of Sydney) (1 paper)
- Partner nations
- AustraliaNew ZealandUnited States
In The Last Decade
Ailsa Langford
7 papers receiving 217 citations
Peers
Comparison fields: 5 of 34
- Pulmonary and Respiratory Medicine 146
- Oncology 54
- Radiology, Nuclear Medicine and Imaging 41
- Biotechnology 16
- Statistics, Probability and Uncertainty 6
Countries citing papers authored by Ailsa Langford
This map shows the geographic impact of Ailsa Langford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ailsa Langford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ailsa Langford more than expected).
Fields of papers citing papers by Ailsa Langford
This network shows the impact of papers produced by Ailsa Langford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ailsa Langford. The network helps show where Ailsa Langford may publish in the future.
Co-authors
The 25 scholars most cited alongside Ailsa Langford, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 118 | |
| 2 | 2018 | 33 | |
| 3 | 2021 | 28 | |
| 4 | 2018 | 15 | |
| 5 | The clinical trials landscape in Australia 2006-2015 | 2017 | 12 |
| 6 | 2021 | 9 | |
| 7 | 2019 | 4 |
About Ailsa Langford
Ailsa Langford is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Neurology, Oncology and Public Health, Environmental and Occupational Health, having authored 7 papers that have together received 219 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Occupational and environmental lung diseases (2 papers), Neuroblastoma Research and Treatments (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Health and Medical Research Impacts (1 paper), Cancer, Lipids, and Metabolism (1 paper) and Cancer Research and Treatments (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (146 citations), Oncology (54 citations), Radiology, Nuclear Medicine and Imaging (41 citations), Biotechnology (16 citations) and Statistics, Probability and Uncertainty (6 citations). Ailsa Langford has collaborated with scholars based in Australia, New Zealand and United States. Frequent co-authors include Martin R. Stockler, Sonia Yip, Nick Pavlakis, Chris Brown, Wei‐Sen Lam, Brett Hughes, Anna K. Nowak, Peey‐Sei Kok, Deme Karikios and W. Joost Lesterhuis. Their work appears in journals such as Journal of Clinical Oncology, Quality of Life Research, The Lancet Oncology, British Journal of Urology and The Sydney eScholarship Repository (The University of Sydney).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.